HEALTH● LOW1h ago · Sep 25, 2026, 9:03 AM
Prime Medicine stock jumps 8% after FDA clears PM647 trial
Seeking Alpha Tech · north america
Prime Medicine's stock jumped after the FDA cleared a trial for its PM647 medicine. This development suggests progress for the company's research and potential future products.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH15m agoGaneshotsav: Maharashtra FDA seizes 6.34 lakh kg of suspected adulterated foodThe HinduHEALTH38m agoMozambique faces rising drug use as trafficking routes fuel local addictionAfricanews [en]HEALTH1h agoSuicide: how lack of social inclusion and economic factors influence the increase in cases among adolescents and young peopleClarínHEALTH3h agoHow AI and robots provide companionship for people with Alzheimer’sEuroNews [en]